Browsing: Longevity

Loyal’s lead drug for senior dogs moves closer to market, marking a rare regulatory milestone for lifespan extension. The gray…

Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs designed to…

Pauling.AI’s Javier Tordable on why aging biology outpaces the business model and how AI can reset the cost curve. We…

Ahead Health lands $6m in seed funding to accelerate digital-first approach to early detection of disease. Swiss preventive health startup…

Phase 1b results for GT-02287 point to biological impact in Parkinson’s, strengthening the case for disease-modifying approaches. Progress in Parkinson’s…

NRG Therapeutics takes a first-in-human step toward disease-modifying treatments for ALS and Parkinson’s, targeting aging at cellular level. There are…

Looking toward London 2026, new speakers broaden the agenda across longevity finance, metabolic health and clinics. The Longevity Show has…

TECregen lands seed funding for mission to combat age-related immune decline by regenerating thymic epithelial cells. Swiss biotech TECregen emerged…

Introduction of ChatGPT Health comes amid widespread existing use of AI for health and wellness questions. Having already made waves…

Company aims to extend human healthspan via a combination of preventive RNAi therapeutics and AI-powered risk prediction. Preventive health biotech…